跳至主要内容
临床试验/JPRN-jRCTs051210021
JPRN-jRCTs051210021招募中2 期

Investigation of clinical effect of vitamin D supplement therapy for pancreatic cancer

Eguchi Hidetoshi0 个研究点目标入组 40 人开始时间: 2021年5月10日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • (1) Patients with confirmed pancreatic cancer classified as resectable pancreatic cancer who are scheduled to undergo surgery in 4 to 8 weeks after 5 to 8 weeks of preoperative systemic chemotherapy or chemoradiation.
  • (2) Age at the time of consent: 20 years or older
  • (3) PS: 0-1 (ECOG grade)
  • (4) Patients with major organ function (bone marrow, liver, kidney, lung, etc.)
  • -White blood cell count: 3,500/mm3 or higher, neutrophil count: 2,000/mm3 or higher,
  • -platelet count: 100,000/mm3 or higher.
  • -Hemoglobin: 9.0 g/dL or higher
  • -Total bilirubin: 2.0 mg/dL or less (However, 3.0 mg/dL or less for patients undergoing biliary drainage for obstructive jaundice caused by tumor)
  • -AST(GOT), ALT(GPT): 150U/L or less
  • -Serum creatinine level: 1.2 mg/dL or less, creatinine clearance: 60 mL/min or more (estimation by the Cockcroft-Gault formula is acceptable)
  • (5)Patients whose written consent to participate in this study has been obtained.

排除标准

  • (1) Patients with the following electrolyte abnormalities:
  • 1) Hypercalcemia (corrected serum Ca level of 11.5 mg/dl or higher (equivalent to Grade 2 in CTCAE ver4.0))
  • 2) Hyper PTH, PTHrPemia (above the standard value)
  • (2) Patients who are using or have taken drugs, supplements, or health foods related to bone metabolism (bisphosphonate, vitamin D, calcium, phosphorus, etc.)
  • (3) Patients who are using steroids
  • (4) Patients who have difficulty with oral treatment
  • (5) Patients with severe mental disorders
  • (6) Patients with severe drug hypersensitivity
  • (7) Patients with pregnant or wishing to pregnant
  • (8) Other patients who are judged by the principal investigator or sub-investigator to be inappropriate for the safe conduct of this study.

研究者

发起方
Eguchi Hidetoshi

相似试验